Skip to main content
Back
NVST logo

Envista Holdings Corp

Data quality: 100%
NVST
NYSE Healthcare Medical - Equipment & Services
$26.14
▲ $0.11 (0.42%)
Mkt Cap: 4.30B
Day Range
$25.53 $26.63
52-Week Range
$14.22 $30.42
Volume
1,691,565
50D / 200D Avg
$26.27 / $21.87
Prev Close
$26.03

Quick Summary

Price History

Financial Trends

Peer Comparison

vs Healthcare sector median (627 peers)

Metric Stock Sector Median
P/E 91.5 0.3
P/B 1.4 3.0
ROE % 1.6 3.7
Net Margin % 1.7 3.8
Rev Growth 5Y % 2.0 10.0
D/E 0.6 0.2

Analyst Price Target

Hold
$27.22 +4.1%
Low: $19.00 High: $35.00
Forward P/E
18.52
Forward EPS
$1.41
EPS Growth (est.)
+0.0%
Est. Revenue
2.84B

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2029 $1.89
$1.87 – $1.92
 3.15B 1
FY2028 $1.73
$1.16 – $2.23
 3.04B 3
FY2027 $1.56
$1.52 – $1.63
 2.95B 10

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2026-02-05 $0.32 $0.38 +17.6%
2025-10-29 $0.27 $0.32 +18.5%
2025-07-31 $0.24 $0.26 +8.3%
2025-05-01 $0.20 $0.24 +20.0%
2025-02-05 $0.23 $0.24 +4.3%
2024-10-30 $0.09 $0.12 +33.3%
2024-08-07 $0.27 $0.11 -59.3%
2024-05-01 $0.31 $0.26 -16.1%

Dividend History

Yield

0.00%

Payout Ratio

0.00%

Growth (3Y)

N/A

Growth (5Y)

N/A

No dividend history available.

Key Takeaways

Revenue grew 2.04% annually over 5 years — modest growth
ROE of 1.56% is below average
Generating 230.40M in free cash flow
P/E of 91.45 — premium valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 6.28%
Cash machine — converts 490.21% of earnings into free cash flow

Growth

Revenue Growth (5Y)
2.04%
Revenue (1Y)8.32%
Earnings (1Y)N/A
FCF Growth (3Y)2.92%

Quality

Return on Equity
1.56%
ROIC3.52%
Net Margin1.73%
Op. Margin8.30%

Safety

Debt / Equity
0.55
Current Ratio2.38
Interest Coverage6.17

Valuation

P/E Ratio
91.45
Forward P/E18.30
P/B Ratio1.38
EV/EBITDA21.24
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 8.32% Revenue Growth (3Y) 2.94%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 2.04% Earnings Growth (5Y) -39.05%
Profitability
Revenue (TTM) 2.72B Net Income (TTM) 47.00M
ROE 1.56% ROA 0.83%
Gross Margin 55.02% Operating Margin 8.30%
Net Margin 1.73% Free Cash Flow (TTM) 230.40M
ROIC 3.52% FCF Growth (3Y) 2.92%
Safety
Debt / Equity 0.55 Current Ratio 2.38
Interest Coverage 6.17
Dividends
Dividend Yield 0.00% Payout Ratio 0.00%
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 91.45 Forward P/E 18.30
P/B Ratio 1.38 P/S Ratio 1.58
PEG Ratio -0.74 Forward PEG N/A
EV/EBITDA 21.24 Fwd EV/EBITDA 10.42
Forward P/S 1.51 Fwd Earnings Yield 5.46%
FCF Yield 5.36%
Market Cap 4.30B Enterprise Value 4.79B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 2.72B 2.51B 2.57B 2.57B 2.51B
Net Income 47.00M -1.12B -100.20M 243.10M 340.50M
EPS (Diluted) 0.28 -6.50 -0.60 1.34 1.48
Gross Profit 1.50B 1.39B 1.45B 1.49B 1.46B
Operating Income 225.70M -1.04B 31.50M 319.20M 306.20M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 5.68B 5.35B 6.61B 6.59B 6.57B
Total Liabilities 2.57B 2.42B 2.43B 2.38B 2.52B
Shareholders' Equity 3.11B 2.93B 4.17B 4.21B 4.06B
Total Debt 1.71B 1.55B 1.65B 1.53B 1.48B
Cash & Equivalents 1.21B 1.07B 940.00M 606.90M 1.07B
Current Assets 2.03B 1.79B 1.74B 1.42B 1.84B
Current Liabilities 852.60M 878.70M 780.80M 1.24B 1.21B

Strategy Scores

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
Custom Cash Flow Compounder
#594 of 1052
42

Recent Activity

Entered Cash Flow Compounder
Mar 24, 2026